ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

7 links3 made here, not in the record6 judgments2 judges (the rules as one: Rule based)0 record changes seen
Claude Opus 5.5Rule basedMade here
Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06663787Personalized Detection ofctDNA for Patients WithHER2-Positive MetastaticBreast Cancer Patients WhoAchieved Durable Responseto Anti-HER2 TreatmentNagoya City Universityactive not recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›No new version seen since tracking began Sep 25, 2026.CONDITIONSBreast NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionNeoplasm MetastasisThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.Neoplasm, ResidualThe registry's MeSH filing›No judgment recorded. Shown as the registry files it.DRUGSTrastuzumabEntry “Trastuzumab (Herceptin)”, read…›Nov 2 · Claude Opus 5.5 · ExposureNov 18 · Rule based · ExposureExposurePertuzumabMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ExposureExposureTrastuzumab deruxtecanMade here · Found by reading; no entr…›Nov 3 · Claude Opus 5.5 · ExposureExposureAdo-Trastuzumab EmtansineMade here · Found by reading; no entr…›Nov 10 · Claude Opus 5.5 · ExposureExposure

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Trastuzumab

From the registry record2 judgments on this link
Role in the study, from the registry to what was judged
RegistryEntry “Trastuzumab (Herceptin)”the record gives no role
→judged=agrees
How the 2 judgments split100%of judgments with a known value say Exposure
Exposure · 2

All judgments on this study

WhenLinkJudgeDecisionState
Nov 2TrastuzumabClaude Opus 5.5ExposureCurrent
Nov 3Pertuzumabmade hereClaude Opus 5.5ExposureCurrent
Nov 3Trastuzumab deruxtecanmade hereClaude Opus 5.5ExposureCurrent
Nov 10Ado-Trastuzumab Emtansinemade hereClaude Opus 5.5ExposureCurrent
Nov 18TrastuzumabRule based · role ruleExposureAgrees
As of nowBreast NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.